Nuclera, the biotechnology company accelerating drug discovery by providing rapid, easy access to functional proteins through ...

Cambridge biotech Nuclera is on the march globally with its much vaunted benchtop eProtein Discovery system following two ...

At the recent ELRIG Drug Discovery conference, Technology Networks<i/> spoke with Dr. Kundan Sharma to learn more about how cell-free expression platforms are transforming membrane protein research.

The emergence of advanced genome editing technologies has revolutionized research in life sciences, offering an unprecedented ...

The emergence of advanced genome editing technologies has revolutionized research in life sciences, offering an unprecedented way to uncover unknown ...

Peptides are everywhere; they’re unavoidable. Insulin is a peptide. So are GLP-1s—the Ozempics and Mounjaros of the world.

Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

Maolac is not designed to imitate human milk, but to understand its biological advantages. Using a proprietary AI-driven ...

Measles and smallpox, for example, are viruses; Streptococcus pneumoniae is a bacterium that causes a range of diseases, ...

The top 10 PharmTech videos of the year cover advanced therapies, high-concentration biologics, major mergers and ...

MISSISSAUGA, ON / ACCESS Newswire / January 7, 2026 / Microbix Biosystems Inc. (TSX:MBX)(OTCQX:MBXBF) (Microbix), a life sciences innovator, manufacturer, and exporter, announces the commercial usage ...